Baird Medical Investment Holdings Limited (BDMD) — Capital Reinvestment Ratio
Baird Medical Investment Holdings Limited (BDMD) has a Capital Reinvestment Ratio of 1.97x as of June 2023, meaning it reinvests 2% of its operating cash flow ($642.95K) in capital expenditures ($1.26 Million). See Baird Medical Investment Holdings Limite (BDMD) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Baird Medical Investment Holdings Limited Capital Reinvestment Ratio (2019–2022)
This chart tracks Baird Medical Investment Holdings Limited's Capital Reinvestment Ratio across 4 annual periods. Check BDMD capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Baird Medical Investment Holdings Limited (2019–2022)
Year-by-year Capital Reinvestment Ratio for Baird Medical Investment Holdings Limited from 2019 to 2022. For live market cap and broader valuation context, see how much is Baird Medical Investment Holdings Limite worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 12.25x | $485.97K | $5.95 Million | ▲ +4539.9% |
| 2021 | 0.26x | $5.26 Million | $1.39 Million | ▲ +57.4% |
| 2020 | 0.17x | $3.91 Million | $655.35K | ▼ -24.8% |
| 2019 | 0.22x | $4.41 Million | $983.78K | — |